Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
PaperCitations, authors & open-access status
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 275 citations, 2019 year and green oa status.
275
Citations
2019
Year
green
OA Status